SciCann Therapeutics
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
69 Yonge St Ste 1010, Toronto, Ontario, ...Phone Number
+972 527331424Website
www.scicann.netRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About SciCann Therapeutics
SciCann Therapeutics is a Canadian-Israeli specialty pharmaceutical company, dedicated to the development and commercialization of novel and disruptive pharmaceutical products that target and modulate the endocannabinoid system. SciCann Therapeutics is active in the fields of inflammatory disorders, oncology and neurodegenerative diseases and develops a line of proprietary cannabinoid-based products for the treatment of chosen life-threatening conditions that present a high level of unmet need. SciCann has created a network of collaborations with leading academic centers and medical institutions in Israel in order to engage in cutting edge science and rigorous clinical studies to develop its products, while using the permissive regulatory climate in Israel for performing its R&D programs quickly and efficiently.Explore more
Popular SearchesSciCann TherapeuticsSciCannSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SciCann Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at SciCann Therapeutics
Click to see if SciCann Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when SciCann Therapeutics launches new products
SciCann Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if SciCann Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SciCann Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once SciCann Therapeutics has new funding data
Check if SciCann Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at SciCann Therapeutics
Find more new buyers
Compare Similar Companies to SciCann Therapeutics
Compare insights from companies similar to SciCann Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SciCann Therapeutics
<$5M
1-10
Private
-
2017
N/A
Company Profile Activity
Activity Insights
SciCann Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SciCann Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SciCann Therapeutics.
SciCann Therapeutics Tech Stack
A closer look at the technologies used by SciCann Therapeutics
SciCann Therapeutics News & Media
SciCann Therapeutics Announces Positive ISA Report for “Steady Stomach” CBD Combination Therapy Patent
TORONTO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- SciCann Therapeutics Inc. (“SciCann”) announced today it has received a positive International Search Authority (ISA) report from the Patent Cooperation Treaty (PCT) for its SCN-001 cannabidiol (CBD) combination therapy patent, the basis of its “Steady Stomach” product.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding SciCann Therapeutics
Sign Up For FreeTo access detailed company insights
SciCann Therapeutics is a Canadian-Israeli specialty pharmaceutical company, dedicated to the development and commercialization of novel and disruptive pharmaceutical products that target and modulate the endocannabinoid system. SciCann Therapeutics is active in the fields of inflammatory disorders, oncology and neurodegenerative diseases and devel... Read More
